Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT Newswires Live01-03

Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.

The iShares Biotechnology ETF (IBB) was down 0.6%.

In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.

Outlook Therapeutics (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.

Hoth Therapeutics (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2600067611?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-03 02:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2600067611","market":"sg","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Mixed in Afternoon Trading","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was down 0.6%.</p><p>In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.</p><p>Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.</p><p><a href=\"https://laohu8.com/S/HOTH\">Hoth Therapeutics</a> (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Mixed in Afternoon Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Mixed in Afternoon Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-03 02:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) was down 0.6%.</p><p>In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.</p><p>Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.</p><p><a href=\"https://laohu8.com/S/HOTH\">Hoth Therapeutics</a> (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XLV","symbol_name":"健康照护类股ETF-SPDR","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2600067611","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2600067611","pubTimestamp":1767379803,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF  easing 0.1%.The iShares Biotechnology ETF  was down 0.6%.In corporate news, Ironwood Pharmaceuticals  shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.Outlook Therapeutics  shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.Hoth Therapeutics  shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XLV":"健康照护类股ETF-SPDR","BK4581":"高盛持仓","BK4007":"制药","IRWD":"Ironwood医药","XBI":"SPDR S&P Biotech ETF","BK4588":"碎股","LABU":"三倍做多标普生物-Direxion","HOTH":"Hoth Therapeutics","OTLK":"Outlook Therapeutics, Inc.","BK4585":"ETF&股票定投概念","IBB":"生物科技指数ETF-iShares Nasdaq","BK4139":"生物科技"},"translate_title":"行业更新：医疗保健股下午交易涨跌互现","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HOTH":1,"IBB":1,"OTLK":1,"XLV":1,"IRWD":1,"LABU":0.6,"XBI":0.6},"content_text":"Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) easing 0.1%.The iShares Biotechnology ETF (IBB) was down 0.6%.In corporate news, Ironwood Pharmaceuticals (IRWD) shares jumped 29% after the company said it expects sales of its irritable bowel syndrome with constipation or chronic constipation treatment, Linzess, in the US to be higher this year compared with 2025.Outlook Therapeutics (OTLK) shares fell 58% after the company said Wednesday the US Food and Drug Administration has issued a complete response letter for its ONS-5010 biologics license application resubmission.Hoth Therapeutics (HOTH) shares climbed 4.4% after it said Friday it has filed two US provisional patent applications aimed at expanding its intellectual property portfolio and establishing an oncology-focused dermatology platform.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2600067611","isCrawlerRequest":true}